Jana Marie Brady, APRN, FNP-BC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 1010 N Mill St, Bowie, TX 76230 Phone: 940-872-1121 |
Lauren Fenoglio, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1010 N Mill St, Bowie, TX 76230 Phone: 940-872-1121 |
Mr. Cesar Raul Alvarado, APRN Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 605 Decatur St, Bowie, TX 76230 Phone: 940-872-2271 |
Mrs. Cynthia L Robertson, RN,FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1010 N Mill St, Bowie, TX 76230 Phone: 940-872-1121 Fax: 940-872-3007 |
Mrs. Stormi Renee Campbell, FNP- C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 700 Us-287 S, Bowie, TX 76230 Phone: 940-872-2283 |
News Archive
Lawmakers in both chambers are calling for Congress to start a conversation about mental health issues in the wake of last week's deadly shooting at a Connecticut elementary school, with one goal of ensuring adequate funding for services for those who need treatment.
Many older adults want to remain active and independent for as long as possible. Seniors want to age in their own homes and avoid moving to institutions or nursing homes.
Cancer of the pancreas is a particularly deadly cancer, claiming over 90% of its victims within 5 years from diagnosis. It resists most standard therapies, including surgery, chemotherapy, radiation therapy, immunotherapy and targeted therapy, and metastasizes early, often before being diagnosed. A cure is possible only with very localized tumors.
For the second straight year, Modern Healthcare magazine has named Texas Health Harris Methodist Hospital Southlake (THHMHS) one of the country's 100 Best Places to Work in Healthcare.
Shire plc, the global specialty biopharmaceutical company, today announced that the European Medicines Agency has approved the purification of REPLAGAL® (agalsidase alfa) drug substance at its new manufacturing facility in Lexington, MA, US. REPLAGAL, Shire's enzyme replacement therapy for the treatment of Fabry disease is the first product that will be made available to patients from the new facility.
› Verified 2 days ago